24 Sep Where Medical Device Innovation Happens Before It Reaches the Clinic: Inside the MedTech Startup Pipeline
Every device a clinician picks up — an infusion pump, a wearable monitor, a surgical robot — has a history that starts long before it appears in a hospital procurement catalogue. Between a founder's first prototype and a nurse using that device on a ward, a device passes through years of design iteration, regulatory review, and funding rounds that most patients, and even many clinicians, never see. Knowing that pipeline is key to questions like why some promising technologies take years to reach patients and others move faster, why certain devices stall after their first clinical pilot, and why the health system's role in adoption begins much earlier than a purchasing decision. According to the FDA (U.S. Food and Drug Administration), the regulatory pathway a medical device follows — whether 510(k) clearance, De Novo authorization, or Premarket Approval — shapes not only how long development takes but what clinical evidence must be generated before a device can reach clinical use.
[caption id="attachment_76229" align="aligncenter" width="500"] Photo by Charlss GonzHu[/caption]
Source: IMAGE[/caption]
